Proteomics International Laboratories Ltd (ASX:PIQ) Published Results Show PromarkerD Outperforms Conventional Tests
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF) is pleased to announce the publication of results of its landmark study demonstrating the PromarkerD test significantly outperforms the current standard of care tests in predicting future kidney function decline.